Eli Lilly Chairman and CEO Dave Ricks joins ‘Mornings with Maria’ to discuss his meeting with President Donald Trump, the president signing an executive order to boost U.S. drug manufacturing and breaking ground on their $4.5 billion foundry.
Tens of thousands of bottles of cholesterol medication have been recalled nationwide.
Zydus Pharmaceuticals (USA) Inc. and AvKARE have recalled their respective medications over manufacturing and quality issues that could impact the drug’s potency, according to two separate releases from the Food and Drug Administration (FDA).
Zydus Pharmaceuticals is recalling approximately 22,896 bottles of Icosapent Ethyl capsules. The medication, manufactured by Softgel Healthcare and distributed in 120-count bottles, was classified as a subpotent drug.
FDA ROLLS BACK ‘RED TAPE’ IN MOVE ALIGNED WITH TRUMP PUSH TO SPEED UP NEW CURES
Oxidation caused…



